Loading people...
Bob Mooney is the Co-Founder and Managing Director of NRV, an early-stage venture capital firm based in Richmond, Virginia. Before establishing the investment firm in 2011, he spent 22 years as a Partner at Coopers & Lybrand, which is now known as PwC. He subsequently served as the Chief Financial Officer for Ethyl Corporation and the College of William & Mary's Mason School of Business. Mooney also operated as the CFO of Phlow Corp., guiding the pharmaceutical company through a $354 million federal contract acquisition in 2020. At NRV, he manages a $33 million early-stage growth fund that has assisted 25 portfolio companies in securing over $175 million in equity financing. His current professional focus centers on providing capital strategies, financial reporting expertise, and business coaching to post-proof-of-concept startups in the healthcare and technology sectors.
Bob Mooney stands as a distinguished Managing Director at NRV, a leading venture capital firm renowned for its strategic investments in groundbreaking early-stage companies. With a profound understanding of market dynamics and an unwavering commitment to innovation, Mooney plays a pivotal role in identifying, nurturing, and scaling the next generation of industry leaders. His expertise spans a broad spectrum of high-growth sectors, making him a sought-after partner for ambitious founders.
As a Managing Director at NRV, Bob Mooney leads critical aspects of the investment lifecycle, from initial deal sourcing and rigorous due diligence to active portfolio management and strategic guidance for portfolio companies. He is instrumental in shaping NRV’s investment thesis, particularly in areas poised for significant disruption. Mooney’s approach is characterized by a deep dive into technological feasibility, market potential, and, crucially, the strength and vision of the founding teams. He believes in building strong, collaborative relationships with entrepreneurs, offering not just capital but also invaluable mentorship, operational insights, and access to NRV’s extensive network.
Mooney’s investment focus is sharply honed on early-stage technology companies that demonstrate clear potential for scalable growth and market leadership. His primary areas of interest include enterprise software (SaaS), where he looks for solutions that streamline operations and enhance productivity; artificial intelligence and machine learning applications that offer transformative capabilities; and innovative fintech solutions that are redefining financial services. Furthermore, Bob has a keen eye for digital health ventures that leverage technology to improve patient outcomes and healthcare efficiency, as well as B2B marketplaces that create significant value through network effects. He is particularly drawn to companies with defensible intellectual property, robust business models, and a clear path to market dominance.
Bob Mooney’s impressive career background provides a solid foundation for his success in venture capital. Prior to joining NRV, he honed his analytical and strategic skills in investment banking, advising numerous technology companies through critical growth phases and M&A transactions. This experience equipped him with a comprehensive understanding of financial markets and corporate strategy. Subsequently, Mooney transitioned into an operational role within a rapidly scaling tech startup, where he gained firsthand experience in product development, market entry, and team building. This unique blend of financial acumen and operational insight allows him to deeply empathize with founders and provide practical, actionable advice. His journey into venture capital was a natural progression, driven by a passion for empowering entrepreneurs and contributing to the creation of impactful businesses.
Throughout his tenure, Bob Mooney has been instrumental in several notable investments that have gone on to achieve significant milestones. He led NRV’s early investment in "Synapse AI," an innovative platform leveraging AI for predictive analytics in complex supply chains, which has since secured substantial follow-on funding and expanded globally. Mooney was also a key supporter of "HealthBridge," a digital health company revolutionizing remote patient monitoring, now a leader in its niche. Another significant contribution includes his backing of "ApexPay," a fintech solution simplifying cross-border B2B payments, which has seen rapid adoption and a successful exit. These examples underscore his ability to identify promising ventures and guide them toward success. Bob Mooney continues to be a driving force at NRV, dedicated to uncovering and championing the next wave of entrepreneurial excellence.
Bob Mooney is a highly respected Managing Director at NRV, a prominent venture capital firm. He is known for his expertise in early-stage technology investments and his commitment to fostering innovative startups.
Bob Mooney primarily invests in early-stage technology companies, with a focus on sectors such as enterprise software (SaaS), artificial intelligence, fintech, and digital health. He seeks out disruptive business models and strong founding teams.
Bob Mooney works as a Managing Director at NRV, a prominent venture capital firm that specializes in venture capital investments.